Abstract

HPV16 predominates across the entire cervical lesion spectrum, with its prevalence significantly increasing with lesion severity. Furthermore, the nonavalent HPV vaccine covers all prevalent oncogenic hrHPV genotypes in this region (except for HPV56). These findings provide crucial epidemiological evidence for optimizing HPV vaccination strategies and cervical cancer screening programs.

Affiliated Institutions

Related Publications

Publication Info

Year
2025
Type
article
Citations
0
Access
Closed

External Links

Citation Metrics

0
OpenAlex

Cite This

Xingjing Luo, Ying Qing Chen, Lei He et al. (2025). HPV genotype distribution and cervical lesion severity in HPV-positive women: a study from the Guizhou Province cervical cancer screening program. Virology Journal . https://doi.org/10.1186/s12985-025-03041-w

Identifiers

DOI
10.1186/s12985-025-03041-w